Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119771712 | 11977171 | 2 | F | 20110615 | 20160705 | 20160129 | 20160712 | EXP | BE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2011-BL-00170BL | BOEHRINGER INGELHEIM | 74.55 | YR | F | Y | 107.00000 | KG | 20160712 | MD | COUNTRY NOT SPECIFIED | BE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119771712 | 11977171 | 1 | PS | BIBF 1120 | NINTEDANIB | 1 | Oral | 400 MG | Y | 205832 | 400 | MG | CAPSULE, HARD | QD | |||||
| 119771712 | 11977171 | 2 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 295 MG | 0 | 295 | MG | QD | |||||||
| 119771712 | 11977171 | 3 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 393 MG | 0 | 393 | MG | QD | |||||||
| 119771712 | 11977171 | 4 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 397.25 MG | 0 | 397.25 | MG | QD | |||||||
| 119771712 | 11977171 | 5 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 576 MG | 0 | 576 | MG | QD | |||||||
| 119771712 | 11977171 | 6 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 819 MG | 0 | 819 | MG | QD | |||||||
| 119771712 | 11977171 | 7 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 880 MG | 0 | 880 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119771712 | 11977171 | 1 | Malignant peritoneal neoplasm |
| 119771712 | 11977171 | 2 | Ovarian cancer |
| 119771712 | 11977171 | 5 | Ovarian cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119771712 | 11977171 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119771712 | 11977171 | Blindness transient | |
| 119771712 | 11977171 | Haemorrhoids | |
| 119771712 | 11977171 | Ototoxicity | |
| 119771712 | 11977171 | Pulmonary embolism | |
| 119771712 | 11977171 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119771712 | 11977171 | 1 | 20110607 | 20110731 | 0 | |
| 119771712 | 11977171 | 2 | 20110711 | 20110711 | 0 | |
| 119771712 | 11977171 | 3 | 20110606 | 20110606 | 0 | |
| 119771712 | 11977171 | 4 | 20110516 | 20110516 | 0 | |
| 119771712 | 11977171 | 5 | 20110711 | 20110711 | 0 | |
| 119771712 | 11977171 | 6 | 20110606 | 20110606 | 0 | |
| 119771712 | 11977171 | 7 | 20110516 | 20110516 | 0 |